Greenwich Lifesciences Inc

GLSI•United States

Healthcare United States Pharmaceutical Preparations

Need professional-grade analysis? Visit stockanalysis.com

$22.91

-17.41%

End of day

Market Cap

$357.72M

P/E Ratio

N/A

Employees

N/A

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio	1W	1M	3M	6M	1Y	5Y	Score
Sortino	—	2.60	2.67	12.63	3.87	—	5.93
Calmar	—	10.23	5.51	23.98	5.31	—	11.39
Sharpe	68.23	1.75	1.66	7.03	2.22	—	7.73
Omega	16.45	1.35	1.31	1.57	1.36	—	2.41
Martin	—	20.40	8.76	46.79	11.17	—	22.15
Ulcer	0.21	7.64	21.60	17.61	17.66	—	15.94

Greenwich Lifesciences Inc (GLSI) Price Performance

Greenwich Lifesciences Inc (GLSI) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $22.91, down 17.41% from the previous close.

Over the past year, GLSI has traded between a low of $7.85 and a high of $33.56. The stock has gained 132.6% over this period. It is currently 31.7% below its 52-week high.

Greenwich Lifesciences Inc has a market capitalization of $357.72M.

About Greenwich Lifesciences Inc

Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers in the United States and Romania. Its lead product candidate is GP2, an immunotherapy, which is in Phase III clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company also develops FLAMINGO-01, which is in Phase III clinical trial designed to evaluate the safety and efficacy of GLSI-100 (GP2 + GM-CSF) in HER2 positive breast cancer patients. Greenwich LifeSciences, Inc. was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. The company was incorporated in 2006 and is headquartered in Stafford, Texas.

Compare Greenwich Lifesciences Inc

Side-by-side comparison against top Healthcare peers.

GLSI vs LLY GLSI vs JNJ GLSI vs ABBV GLSI vs RHHBF GLSI vs RHHVF GLSI vs AZN

Company Info

Sector: Healthcare
Industry: Pharmaceutical Preparations
Exchange: United States
Currency: USD
Country: United States

Financial Metrics

Revenue (TTM): N/A
EBITDA: $-19,584,406
Profit Margin: N/A
EPS (TTM): -0.69
Book Value: 0.16

Technical Indicators

52 Week High: $34.10
52 Week Low: $7.78
50 Day MA: $26.35
200 Day MA: $15.70
Beta: 1.53

Valuation

Trailing P/E: N/A
Forward P/E: -31.49
Price/Sales: N/A
Price/Book: 163.42
Enterprise Value: $311.41M